Ken Locke currently serves as Vice President, Manufacturing and Supply Chain at Carisma Therapeutics. Prior to joining Carisma, Ken served as Global Head of Cell Therapy External Manufacturing and Strategic Sourcing at Bristol Myers Squibb (formerly Celgene/Juno Therapeutics) where he was responsible for all external manufacturing operations for plasmid, viral vector and cell processing. Prior to BMS, Ken was Executive Director at Novartis supporting global materials and services sourcing for all Technical R&D as well as Cell and Gene Therapies. He has more than 25 years of pharmaceutical and biotechnology experience, including discovery, laboratory automation, sourcing/contracting strategy, supply chain and manufacturing.